Concert Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Summary

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) will participate in two upcoming virtual investor conferences. The Jefferies Virtual Healthcare Conference will feature a fireside chat presentation on June 2, 2021, at 3:30 p.m. ET, while the JMP Securities Life Sciences Conference will take place on June 16, 2021, at 11:30 a.m. ET. Interested parties can access a live webcast of these events on the company's website, which will also host a replay for two weeks post-event.

Concert focuses on developing small molecule drugs using its DCE Platform®, particularly targeting alopecia areata treatment.

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will participate at the following upcoming virtual investor conferences:

• The Jefferies Virtual Healthcare Conference
  • Fireside Chat Presentation on June 2, 2021 at 3:30 p.m. ET

• The JMP Securities Life Sciences Conference
  • Fireside Chat Presentation on June 16, 2021 at 11:30 a.m. ET

A live webcast of the presentations may be accessed in the Investors section of the Company’s website at www.concertpharma.com. Please log on to the Concert website approximately 15 minutes prior to the scheduled webcast to ensure adequate time for any software downloads that may be required. A replay of the webcasts will be available on Concert’s website for two weeks following the presentations.

About Concert

Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform^® (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert’s lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates. For more information please visit www.concertpharma.com or follow us on Twitter at @ConcertPharma or on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210526005066/en/

FAQ

What investor conferences is Concert Pharmaceuticals participating in?

Concert Pharmaceuticals will participate in the Jefferies Virtual Healthcare Conference on June 2, 2021, and the JMP Securities Life Sciences Conference on June 16, 2021.

When is the Jefferies Virtual Healthcare Conference presentation?

The Jefferies Virtual Healthcare Conference presentation is scheduled for June 2, 2021, at 3:30 p.m. ET.

When is the JMP Securities Life Sciences Conference presentation?

The JMP Securities Life Sciences Conference presentation will be held on June 16, 2021, at 11:30 a.m. ET.

How can I access the webcasts for Concert Pharmaceuticals' presentations?

The webcasts can be accessed through the Investors section of Concert Pharmaceuticals' website approximately 15 minutes before the scheduled start times.

What is the focus of Concert Pharmaceuticals' drug development?

Concert Pharmaceuticals focuses on developing small molecule drugs, particularly for treating alopecia areata, using its DCE Platform®.